STABILITY-INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE ANALYSIS OF DOXEPIN HYDROCHLORIDE IN BULK AND PHARMACEUTICAL DOSAGE FORM

RAJESH R.

doi:10.22159/ijpps.2024v16i4.50126

Authors

RAJESH R. Department of Pharmaceutical Analysis, Acharya and BM Reddy College of Pharmacy. Soldevanahalli, Bengaluru-560107, India https://orcid.org/0000-0002-6400-783X

DOI:

https://doi.org/10.22159/ijpps.2024v16i4.50126

Keywords:

Doxepine hydrochloride, HPLC, Validation, Stability studies

Abstract

Objective: A simple, reliable, and rapid RP-HPLC method showing stability has been established to detect Doxepin Hydrochloride (DOX) with its degraded products. The proposed method has been validated for specificity, linearity, system suitability, accuracy, precision, robustness, LOD, and LOQ as per ICH guidelines. All parameters were found to be within the accepted limits, affirming the method's reliability.

Methods: Analysis was conducted using RP-HPLC on a Phenomenex C18 Luna column (250 mm × 4.6 mm id, 5 µm) with a mobile phase comprising methanol, acetonitrile, and buffer (40:30:30, v/v/v) and a flow rate of 0.5 ml/min. The detection was performed with a UV detector set at 254 nm. Diverse methods have been employed to investigate forced degradation studies, including acid-base hydrolysis, photolysis, thermal degradation, and oxidation. These studies were conducted both in bulk and in capsule formulations of DOX.

Results: The retention time (tR) of DOX was 2.92 minutes, and all parameters met acceptable limit values. The response exhibited linearity over a concentration range of 10 to 50 µg/ml (R²= 0.9974). The percentage of DOX recovered from the pharmaceutical cream dosage form ranged from 97.67% to 101%. Sensitivity levels for the developed method were indicated by limit of detection (LOD) and limit of quantification (LOQ) values of 0.40–0.50 µg/ml. The proposed method was validated according to ICH guidelines.

Conclusion: Hence, a simple, reliable, accurate, and precise HPLC method was developed, proving suitable for the analysis of DOX in both bulk and commercial formulations.

Downloads

Download data is not yet available.

References

Katwala J, Kumar AK, Sejpal JJ, Terrence M, Mishra M. Therapeutic rationale for low dose doxepin in insomnia patients. Asian Pac J Trop Dis. 2013 Aug;3(4):331-6. doi: 10.1016/S2222-1808(13)60080-8, PMCID PMC4027305.

Giogi N, Rajesh R, Selva Kumar K. Quantitative and qualitative analytical techniques for doxepin hydrochloride: an overview. IJPPR Hum. 2020 Jul;19(1):14-27.

Farjami F, Fasihi F, Alimohammadi F, Moradi SE. Electrochemical behavior and highly sensitive voltammetric determination of doxepin in pharmaceutical preparations and blood serum using carbon ionic liquid electrode. Iran J Pharm Res. 2019;18(1):91-101. PMID 31089347, PMCID PMC6487409.

Yu LX, Amidon G, Khan MA, Hoag SW, Polli J, Raju GK. Understanding pharmaceutical quality by design. AAPS J. 2014 Jul;16(4):771-83. doi: 10.1208/s12248-014-9598-3, PMID 24854893, PMCID PMC4070262.

Sanjay B, Dinesh S, Neha S. Stability testing of pharmaceutical products. JAPS. 2012 Mar;2(3):129-38.

Blessy M, Patel RD, Prajapati PN, Agrawal YK. Development of forced degradation and stability indicating studies of drugs-a review. J Pharm Anal. 2014 Jun;4(3):159-65. doi: 10.1016/j.jpha.2013.09.003, PMID 29403878.

Soares S, Barroso M, Gallardo E. A review of current bioanalytical approaches in sample pretreatment techniques for the determination of antidepressants in biological specimens. Rev Anal Chem. 2021 Apr;40(1):12-32. doi: 10.1515/revac-2021-0124.

Rahman N, Siddiqui S, Azmi SN. Spectrofluorimetric method for the determination of doxepin hydrochloride in commercial dosage forms. AAPS PharmSciTech. 2009;10(4):1381-7. doi: 10.1208/s12249-009-9341-z, PMID 19936937, PMCID PMC2799607.

Patel NP, Sanyal M, Sharma N, Patel DS, Shrivastav PS, Patel BN. Highly sensitive LC-MS/MS method to estimate doxepin and its metabolite nordoxepin in human plasma for a bioequivalence study. J Pharm Anal. 2018 Dec;8(6):378-85. doi: 10.1016/j.jpha.2017.06.004, PMID 30595944, PMCID PMC6308917.

Adamczyk M, Fishpaugh JR, Harrington C. Quantitative determination of E- and Z-doxepin and E and Z-desmethyldoxepin by high-performance liquid chromatography. Ther Drug Monit. 1995 Aug;17(4):371-6. doi: 10.1097/00007691-199508000-00010, PMID 7482692.

Nagalaxmi M, Ajitha M. Stability indicating RP-HPLC method development and method validation for content estimation of doxepin in doxepin capsules. IJARMPS. 2022 Dec;7(6):48-61.

Sanz R, Clares B, Mallandrich M, Casals I, Bellido D, Calpena A. Validation of doxepin quantitative determination methods for their application to in vitro, ex vivo and in vivo studies. Curr Pharm Anal. 2015 Nov;11(4):269-77. doi: 10.2174/1573412911666150410003357.

Geogin J, Patel M, Teraiya N, Chauhan A, Trivedi P, Patel B. Determination of doxepin hydrochloride in spiked human plasma and capsule after derivatization with eosin Y using resonance rayleigh scattering, second-order scattering and frequency doubling scattering methods. Luminescence. 2023 Jun;38(6):753-61. doi: 10.1002/bio.4503, PMID 37060157.

Bhavani P, Prasada RK, Mohan S. Stability-indicating RP-HPLC method for the determination of doxepin, benzyl alcohol and capsaicin in bulk and pharmaceutical dosage forms. J Emerg Technol Innov Res. 2018 Aug;5(8):97-111.

Q1A. Stability testing of new drug substances and products. ICH harmonised tripartite guidelines. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Vol. R2; 2003.

Q2 (R1) validation of analytical procedures: text and methodology. ICH harmonised tripartite guideline. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Chicago, USA; 2005.

Veneela AS, Rajitha G, Narikimalli A. A stability indicating RP-HPLC method development and validation for the simultaneous estimation of daunorubicin and cytarabine in bulk and pharmaceutical dosage form. Asian J Pharm Clin Res. 2022 May;15(5):58-63. doi: 10.22159/ajpcr.2022.v15i5.43682.

Ahmad S, Khabiya P, Au T, Raheman Bakhshi A. Quality by design approach to develop stability indicating reversed-phase high-performance liquid chromatography method development for ambroxol. Asian J Pharm Clin Res 2021;14(12):44-9. doi: 10.22159/ajpcr.2021.v14i12.42939.

Verma A, Singla S, Palia P. The development of forced degradation and stability indicating studies of drugs- a review. Asian J Pharm Res Dev. 2022;10(2):83-9. doi: 10.22270/ajprd.v10i2.1104.